Our findings indicate benzo(a)pyrene exposure as a high-risk factor for SCLC and poor outcomes in patients, with the underlying mechanism being the activation of cancer stemness of SCLC cells via the AhR/PKA/SOX2 axis [148]. This evidence concerns the gene SOX2 and cancer.